FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116940865> ?p ?o ?g. }

• W2116940865 endingPage "1561" @default.
• W2116940865 startingPage "1549" @default.
• W2116940865 abstract "Between 1978 and 1998, 533 prostate adenocarcinoma patients were treated with mixed photon-neutron radiotherapy. We report on a retrospective series of patients for whom the side effects of the treatment and their impact on quality of life were assessed by a mailed questionnaire.The European Organization for Research and Treatment of Cancer quality-of-life core questionnaire and a prostate-specific questionnaire were used. Between 1990 and 1996, 308 consecutive patients were treated. Two protocols were used: pelvic fields (50 Gy equivalent photons, 2 Gy/fraction) followed by a prostate boost (66 Gy) or prostate alone. The neutron/photon ratio varied. The questionnaire was mailed to 262 patients presumed to be alive.Of the 262 patients, 230 replied. Of the 230 patients, 73% had no trouble doing strenuous activities and 4% had trouble with taking a short walk. The overall physical condition and quality-of-life questions received a mean score of 5.2 and 5.3 on a 7-point scale, respectively. Twenty-two percent had bowel movements at least four times daily, and 6% did so six times or more. Retaining stool was a problem in 26%, and only 38% reported full continence; 17% urinated four times or more nightly. Urinary incontinence was scored as quite a bit or very much in 11% and 5%, respectively. Hematuria and dysuria (pain) were reported by 7% and 16%, respectively, mainly as moderate. Only 28% reported easy erections, but 75% judged the sexual change acceptable. A greater neutron/photon ratio was significantly associated with more bowel problems (p = 0.003).Mixed photon-neutron therapy for prostate cancer was associated with significant patient-reported side effects. Their significant effect on patients' quality of life is described." @default.
• W2116940865 created "2016-06-24" @default.
• W2116940865 creator A5022728845 @default.
• W2116940865 creator A5024767864 @default.
• W2116940865 creator A5032311952 @default.
• W2116940865 creator A5063656738 @default.
• W2116940865 creator A5084194739 @default.
• W2116940865 creator A5084429212 @default.
• W2116940865 creator A5088206928 @default.
• W2116940865 date "2004-04-01" @default.
• W2116940865 modified "2023-10-16" @default.
• W2116940865 title "Retrospective analysis of results of p(65)+Be neutron therapy for treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Leuve. Part II: Side effects and their influence on quality of life measured with QLQ-C30 of EORTC" @default.
• W2116940865 cites W1493773294 @default.
• W2116940865 cites W1548119639 @default.
• W2116940865 cites W1657562951 @default.
• W2116940865 cites W1695458720 @default.
• W2116940865 cites W1746855001 @default.
• W2116940865 cites W1875462884 @default.
• W2116940865 cites W1890419597 @default.
• W2116940865 cites W1946864894 @default.
• W2116940865 cites W1969355197 @default.
• W2116940865 cites W1969938531 @default.
• W2116940865 cites W1970303557 @default.
• W2116940865 cites W1976725018 @default.
• W2116940865 cites W1978663841 @default.
• W2116940865 cites W1979914233 @default.
• W2116940865 cites W1985775831 @default.
• W2116940865 cites W1989688413 @default.
• W2116940865 cites W1990050184 @default.
• W2116940865 cites W1998290948 @default.
• W2116940865 cites W2004071170 @default.
• W2116940865 cites W2014011665 @default.
• W2116940865 cites W2022766832 @default.
• W2116940865 cites W2023807811 @default.
• W2116940865 cites W2026807216 @default.
• W2116940865 cites W2027226328 @default.
• W2116940865 cites W2027818653 @default.
• W2116940865 cites W2028742034 @default.
• W2116940865 cites W2031586124 @default.
• W2116940865 cites W2032554540 @default.
• W2116940865 cites W2038409196 @default.
• W2116940865 cites W2040091965 @default.
• W2116940865 cites W2048290254 @default.
• W2116940865 cites W2056643793 @default.
• W2116940865 cites W2056824601 @default.
• W2116940865 cites W2058200992 @default.
• W2116940865 cites W2059710722 @default.
• W2116940865 cites W2064199621 @default.
• W2116940865 cites W2072650440 @default.
• W2116940865 cites W2076392304 @default.
• W2116940865 cites W2076883113 @default.
• W2116940865 cites W2077437308 @default.
• W2116940865 cites W2081354777 @default.
• W2116940865 cites W2084800358 @default.
• W2116940865 cites W2091013692 @default.
• W2116940865 cites W2092255924 @default.
• W2116940865 cites W2093485750 @default.
• W2116940865 cites W2094869833 @default.
• W2116940865 cites W2100446131 @default.
• W2116940865 cites W2102343163 @default.
• W2116940865 cites W2103429819 @default.
• W2116940865 cites W2110488527 @default.
• W2116940865 cites W2136713730 @default.
• W2116940865 cites W2137900501 @default.
• W2116940865 cites W2144262393 @default.
• W2116940865 cites W2144498681 @default.
• W2116940865 cites W2144819244 @default.
• W2116940865 cites W2150846672 @default.
• W2116940865 cites W2157868227 @default.
• W2116940865 cites W2159306398 @default.
• W2116940865 cites W2160440737 @default.
• W2116940865 cites W2167571044 @default.
• W2116940865 cites W2182041435 @default.
• W2116940865 cites W2325343629 @default.
• W2116940865 cites W2405232286 @default.
• W2116940865 cites W2505043961 @default.
• W2116940865 cites W2599228863 @default.
• W2116940865 doi "https://doi.org/10.1016/j.ijrobp.2003.09.001" @default.
• W2116940865 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15050336" @default.
• W2116940865 hasPublicationYear "2004" @default.
• W2116940865 type Work @default.
• W2116940865 sameAs 2116940865 @default.
• W2116940865 citedByCount "9" @default.
• W2116940865 countsByYear W21169408652012 @default.
• W2116940865 countsByYear W21169408652013 @default.
• W2116940865 countsByYear W21169408652014 @default.
• W2116940865 crossrefType "journal-article" @default.
• W2116940865 hasAuthorship W2116940865A5022728845 @default.
• W2116940865 hasAuthorship W2116940865A5024767864 @default.
• W2116940865 hasAuthorship W2116940865A5032311952 @default.
• W2116940865 hasAuthorship W2116940865A5063656738 @default.
• W2116940865 hasAuthorship W2116940865A5084194739 @default.
• W2116940865 hasAuthorship W2116940865A5084429212 @default.
• W2116940865 hasAuthorship W2116940865A5088206928 @default.
• W2116940865 hasConcept C121608353 @default.
• W2116940865 hasConcept C126322002 @default.
• W2116940865 hasConcept C126894567 @default.
• W2116940865 hasConcept C141071460 @default.

• next